AR057887A1 - Composiciones y metodos de tratamiento de trastornos del snc - Google Patents
Composiciones y metodos de tratamiento de trastornos del sncInfo
- Publication number
- AR057887A1 AR057887A1 ARP060104925A ARP060104925A AR057887A1 AR 057887 A1 AR057887 A1 AR 057887A1 AR P060104925 A ARP060104925 A AR P060104925A AR P060104925 A ARP060104925 A AR P060104925A AR 057887 A1 AR057887 A1 AR 057887A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- unsubstituted
- compound
- treatment
- branched
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Reivindicacion 1: Una composicion farmacéutica, caractetizada porque comprende - un primer compuesto que tiene la siguiente formula (1) en donde R1 puede ser alquilo (C1-8), ramificado o no ramificado; un anillo carbocíclico (C1-8) sustituido o no sustituido; haloalquilo ramificado o no ramificado, un anillo arilo o heteroarilo sustituido o no sustituido o un anillo (CH2)p-arilo o (CH2)p-heteroarilo sustituido o no susittuido, donde p es 1, 2, 3 o 4; R2 y R3, tomados juntos, forman un anillo de piperidina; pirrolidina, azepán, aziridina o azetidina sustituido o no sustituido; y n es 1, 2, 3, 4, 5 o 6; y sales y/o ésteres aceptables para uso farmacéutico del mismo, donde el primer compuesto está presente en una cantidad tal que si se administrara sola no mejora sustancialmente la memoria; y - un segundo compuesto que es un inhibidor de colinesterasa o acetilcolinesterasa y está presente en una cantidad tal que si se administrara sola no mejora sustancialmente la memoria. Moduladores de tienopiridinona del receptor 5-HT4, y en particular el uso de estos compuestos y sus composiciones farmacéuticas, por ejemplo, en el tratamiento, la modulacion y/o la prevencion de las afecciones fisiologicas asociadas con la accion de serotonina, tal como en el tratamiento del mal de Alzheimer, trastornos cognitivos, depresion y ansiedad.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/271,019 US7598265B2 (en) | 2004-09-30 | 2005-11-10 | Compositions and methods for treating CNS disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AR057887A1 true AR057887A1 (es) | 2007-12-26 |
Family
ID=37946751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060104925A AR057887A1 (es) | 2005-11-10 | 2006-11-09 | Composiciones y metodos de tratamiento de trastornos del snc |
Country Status (17)
Country | Link |
---|---|
US (2) | US7598265B2 (es) |
EP (1) | EP1959954A2 (es) |
JP (1) | JP2009515877A (es) |
KR (1) | KR20080067001A (es) |
CN (1) | CN101340908A (es) |
AR (1) | AR057887A1 (es) |
AU (1) | AU2006315854A1 (es) |
BR (1) | BRPI0618493A2 (es) |
CA (1) | CA2629312C (es) |
CR (1) | CR10062A (es) |
EA (1) | EA200801302A1 (es) |
IL (1) | IL191168A0 (es) |
MA (1) | MA30037B1 (es) |
NO (1) | NO20082679L (es) |
TW (1) | TW200735868A (es) |
WO (1) | WO2007058805A2 (es) |
ZA (1) | ZA200804951B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050222175A1 (en) * | 2004-03-31 | 2005-10-06 | Dhanoa Dale S | New piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US7612078B2 (en) * | 2003-03-31 | 2009-11-03 | Epix Delaware, Inc. | Piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US7488736B2 (en) * | 2004-05-17 | 2009-02-10 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
US7598265B2 (en) * | 2004-09-30 | 2009-10-06 | Epix Delaware, Inc. | Compositions and methods for treating CNS disorders |
US7576211B2 (en) * | 2004-09-30 | 2009-08-18 | Epix Delaware, Inc. | Synthesis of thienopyridinone compounds and related intermediates |
US7407966B2 (en) * | 2004-10-07 | 2008-08-05 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
CA2595607C (en) | 2005-01-25 | 2014-07-15 | Epix Delaware, Inc. | Substituted arylamine compounds and their use as 5-ht6 modulators |
GB0526258D0 (en) * | 2005-12-22 | 2006-02-01 | Novartis Ag | Organic compounds |
WO2010065743A2 (en) * | 2008-12-03 | 2010-06-10 | Nanotherapeutics, Inc. | Bicyclic compounds and methods of making and using same |
JP2012523437A (ja) * | 2009-04-13 | 2012-10-04 | セラヴァンス, インコーポレーテッド | 認知障害の治療のための5−ht4受容体アゴニスト化合物 |
US20230139125A1 (en) * | 2021-02-04 | 2023-05-04 | Richard Natrillo | Dietary supplement for improving brain performance |
Family Cites Families (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3069412A (en) | 1958-08-15 | 1962-12-18 | Fmc Corp | N-aminoazetidine and preparation thereof |
CA933923A (en) | 1969-12-19 | 1973-09-18 | Eichenberger Kurt | Process for the manufacture of new thiopyranes |
GB1570494A (en) | 1975-11-28 | 1980-07-02 | Ici Ltd | Thienopyrimidine derivatives and their use as pesticides |
DE2925175A1 (de) | 1979-06-22 | 1981-01-08 | Basf Ag | Verfahren zur herstellung von isatosaeureanhydriden |
IT1203323B (it) | 1987-02-02 | 1989-02-15 | Hoechst Italia Spa | Additivo fotoattivatore per composizioni polimeriche costituito dal sale metallico di una cera ossidata |
US5236917A (en) | 1989-05-04 | 1993-08-17 | Sterling Winthrop Inc. | Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
DE4008726A1 (de) | 1990-03-19 | 1991-09-26 | Basf Ag | Thieno(2,3-d)pyrimidinderivate |
DE4023270A1 (de) * | 1990-07-21 | 1992-02-06 | Hoechst Ag | Hydrophile mischpolymere sowie deren verwendung in der reprographie |
US5219864A (en) | 1991-03-12 | 1993-06-15 | Kyowa Hakko Kogyo Co., Ltd. | Thienopyridine derivatives |
US5155115A (en) | 1991-03-12 | 1992-10-13 | Kyowa Hakko Kogyo Co., Ltd. | Thienopyridine derivatives |
US5227387A (en) | 1991-09-03 | 1993-07-13 | Dowelanco | Quinoline nematicidal method |
DE4138820A1 (de) | 1991-11-26 | 1993-05-27 | Basf Ag | Chinolin-3-carbonsaeureamide, deren herstellung und verwendung |
DE4208254A1 (de) | 1992-03-14 | 1993-09-16 | Hoechst Ag | Substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel und fungizid |
DE4227747A1 (de) | 1992-08-21 | 1994-02-24 | Basf Ag | Heteroaromatisch kondensierte Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung |
US5409948A (en) | 1992-11-23 | 1995-04-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for treating cognitive disorders with phenserine |
JPH06239858A (ja) | 1993-02-16 | 1994-08-30 | Otsuka Pharmaceut Co Ltd | 末梢血管拡張剤 |
GB9306460D0 (en) | 1993-03-29 | 1993-05-19 | Smithkline Beecham Plc | Novel compounds |
JPH07324087A (ja) * | 1994-04-04 | 1995-12-12 | Taisho Pharmaceut Co Ltd | 複素環化合物 |
TW449600B (en) | 1994-04-19 | 2001-08-11 | Takeda Chemical Industries Ltd | Condensed-ring thiophene derivatives, their production and use |
JP3829879B2 (ja) | 1994-05-18 | 2006-10-04 | 大正製薬株式会社 | キノリンカルボン酸誘導体 |
GB2295387A (en) | 1994-11-23 | 1996-05-29 | Glaxo Inc | Quinazoline antagonists of alpha 1c adrenergic receptors |
DE19636769A1 (de) | 1996-09-10 | 1998-03-12 | Basf Ag | 3-Substituierte Pyrido [4',3':4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung |
US6979309B2 (en) * | 1997-02-14 | 2005-12-27 | Nxstage Medical Inc. | Systems and methods for performing blood processing and/or fluid exchange procedures |
DE19724980A1 (de) | 1997-06-13 | 1998-12-17 | Basf Ag | 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung |
JPH11130777A (ja) | 1997-08-13 | 1999-05-18 | Takeda Chem Ind Ltd | チエノピリジン誘導体、その中間体およびそれらの製造法 |
ATE404539T1 (de) | 1997-10-02 | 2008-08-15 | Eisai R&D Man Co Ltd | Kondensierte pyridinderivate |
US6103903A (en) | 1998-02-26 | 2000-08-15 | Neurogen Corporation | 4-(4-piperidylmethyhlamino) substituted heteroaryl fused pyridines: GABA brain receptor ligands |
DE19815026A1 (de) | 1998-04-03 | 1999-10-07 | Hoechst Schering Agrevo Gmbh | Substituierte Piperidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide |
WO1999051932A2 (en) * | 1998-04-08 | 1999-10-14 | Moshier Gary S | Launched munition neutralization of buried mines |
IL139787A0 (en) | 1998-06-02 | 2002-02-10 | Osi Pharm Inc | PYRROLO [2, 3d] PYRIMIDINE COMPOSITIONS AND THEIR USE |
US6232320B1 (en) | 1998-06-04 | 2001-05-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
AU5259100A (en) | 1999-04-28 | 2000-11-10 | Respiratorius Ab | Medicament |
SE9902987D0 (sv) | 1999-08-24 | 1999-08-24 | Astra Pharma Prod | Novel compounds |
AU763033B2 (en) | 1999-10-01 | 2003-07-10 | Japan Energy Corporation | Novel quinazoline derivatives |
EP1270568A1 (en) | 2001-06-19 | 2003-01-02 | Biofrontera Pharmaceuticals AG | 1-methyl-4-(3-ethoxy-9h-thioxanthene-ylidene)-piperidine and its use as 5-HT2B and/or H1 antagonist |
WO2003020728A1 (en) | 2001-08-30 | 2003-03-13 | Pharmacia & Upjohn Company | 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS |
MXPA03000145A (es) | 2002-01-07 | 2003-07-15 | Pfizer | Compuestos de oxo u oxi-piridina como moduladores de receptores 5-ht4. |
AU2003298514A1 (en) | 2002-05-17 | 2004-05-04 | Eisai Co., Ltd. | Methods and compositions using cholinesterase inhibitors |
US20040138238A1 (en) | 2002-08-08 | 2004-07-15 | Dhanoa Dale S. | Substituted aminopyrimidine compounds as neurokinin antagonists |
AU2003255845A1 (en) | 2002-08-22 | 2004-03-11 | Piramed Limited | Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents |
WO2004030629A2 (en) | 2002-10-01 | 2004-04-15 | Predix Pharmaceuticals | Novel neurokinin antagonists and methods of use thereof |
US7153858B2 (en) | 2003-01-31 | 2006-12-26 | Epix Delaware, Inc. | Arylpiperazinyl compounds |
ATE511511T1 (de) | 2003-03-31 | 2011-06-15 | Trovis Pharmaceuticals Llc | Neue piperidinylaminothienoä2,3-dü pyrimidinverbindungen |
US20050222175A1 (en) | 2004-03-31 | 2005-10-06 | Dhanoa Dale S | New piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US7612078B2 (en) | 2003-03-31 | 2009-11-03 | Epix Delaware, Inc. | Piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US7119205B2 (en) | 2003-05-16 | 2006-10-10 | Abbott Laboratories | Thienopyridones as AMPK activators for the treatment of diabetes and obesity |
RU2357734C2 (ru) | 2003-07-25 | 2009-06-10 | Ф.Хоффманн-Ля Рош Аг | КОМБИНАЦИЯ АНТАГОНИСТА РЕЦЕПТОРА mGluR2 И ИНГИБИТОРА ФЕРМЕНТА AChE ДЛЯ ЛЕЧЕНИЯ ОСТРЫХ И/ИЛИ ХРОНИЧЕСКИХ НЕВРОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ |
GB0322140D0 (en) | 2003-09-22 | 2003-10-22 | Pfizer Ltd | Combinations |
ZA200603165B (en) | 2003-11-03 | 2007-07-25 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
US7488736B2 (en) * | 2004-05-17 | 2009-02-10 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
US20060084806A1 (en) | 2004-07-21 | 2006-04-20 | Ramasubramanian Sridharan | Processes for the preparation of imidazo[1,2-a] pyridine derivatives |
US7598265B2 (en) | 2004-09-30 | 2009-10-06 | Epix Delaware, Inc. | Compositions and methods for treating CNS disorders |
US7407966B2 (en) | 2004-10-07 | 2008-08-05 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
US7576211B2 (en) | 2004-09-30 | 2009-08-18 | Epix Delaware, Inc. | Synthesis of thienopyridinone compounds and related intermediates |
CA2595607C (en) | 2005-01-25 | 2014-07-15 | Epix Delaware, Inc. | Substituted arylamine compounds and their use as 5-ht6 modulators |
JP2009520688A (ja) | 2005-11-23 | 2009-05-28 | エピックス デラウェア, インコーポレイテッド | S1p受容体調節化合物およびそれらの使用 |
AR061637A1 (es) | 2006-06-26 | 2008-09-10 | Epix Delaware Inc | Composiciones y metodos de tratamiento de trastornos del snc |
WO2008045558A2 (en) | 2006-10-12 | 2008-04-17 | Epix Delaware, Inc. | Benzothiadiazine compounds and their use |
WO2008060632A2 (en) | 2006-11-17 | 2008-05-22 | Epix Delaware, Inc. | Adenosine analogs and their use |
-
2005
- 2005-11-10 US US11/271,019 patent/US7598265B2/en active Active
-
2006
- 2006-11-06 BR BRPI0618493-6A patent/BRPI0618493A2/pt not_active IP Right Cessation
- 2006-11-06 JP JP2008540098A patent/JP2009515877A/ja active Pending
- 2006-11-06 KR KR1020087013812A patent/KR20080067001A/ko not_active Application Discontinuation
- 2006-11-06 AU AU2006315854A patent/AU2006315854A1/en not_active Abandoned
- 2006-11-06 CN CNA2006800467370A patent/CN101340908A/zh active Pending
- 2006-11-06 EA EA200801302A patent/EA200801302A1/ru unknown
- 2006-11-06 CA CA2629312A patent/CA2629312C/en active Active
- 2006-11-06 EP EP06827533A patent/EP1959954A2/en not_active Ceased
- 2006-11-06 WO PCT/US2006/043140 patent/WO2007058805A2/en active Application Filing
- 2006-11-09 AR ARP060104925A patent/AR057887A1/es not_active Application Discontinuation
- 2006-11-09 TW TW095141449A patent/TW200735868A/zh unknown
-
2008
- 2008-04-30 IL IL191168A patent/IL191168A0/en unknown
- 2008-06-06 MA MA31013A patent/MA30037B1/fr unknown
- 2008-06-06 ZA ZA200804951A patent/ZA200804951B/xx unknown
- 2008-06-10 CR CR10062A patent/CR10062A/es not_active Application Discontinuation
- 2008-06-10 NO NO20082679A patent/NO20082679L/no not_active Application Discontinuation
-
2009
- 2009-09-30 US US12/570,510 patent/US20110195953A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20110195953A1 (en) | 2011-08-11 |
EA200801302A1 (ru) | 2009-02-27 |
TW200735868A (en) | 2007-10-01 |
EP1959954A2 (en) | 2008-08-27 |
KR20080067001A (ko) | 2008-07-17 |
ZA200804951B (en) | 2009-04-29 |
AU2006315854A1 (en) | 2007-05-24 |
NO20082679L (no) | 2008-06-10 |
BRPI0618493A2 (pt) | 2011-08-30 |
CR10062A (es) | 2009-05-14 |
US20060234998A1 (en) | 2006-10-19 |
CN101340908A (zh) | 2009-01-07 |
IL191168A0 (en) | 2008-12-29 |
CA2629312C (en) | 2014-08-12 |
WO2007058805A2 (en) | 2007-05-24 |
CA2629312A1 (en) | 2007-05-24 |
JP2009515877A (ja) | 2009-04-16 |
WO2007058805A3 (en) | 2007-10-04 |
US7598265B2 (en) | 2009-10-06 |
MA30037B1 (fr) | 2008-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR057887A1 (es) | Composiciones y metodos de tratamiento de trastornos del snc | |
AR083849A1 (es) | Antagonistas de mdm2 de espiro-oxindol | |
AR078756A1 (es) | Moduladores alostericos positivos (map) | |
AR065322A1 (es) | 2-aminooxazolinas comoligandos de taar1 | |
AR058885A1 (es) | Compuestos de piperidina 3,5-sustituidos | |
AR072962A1 (es) | Derivados de pirimidin-4-ona sustituidos | |
AR056838A1 (es) | Derivados de 1,2,5-tiadiazol | |
AR055878A1 (es) | Derivados de ciclopropanocarboxamida | |
AR063331A1 (es) | Derivados de biaril eter urea y composiciones farmaceuticas | |
AR056320A1 (es) | Derivados de cromano y cromeno, procesos de obtencion, composiciones farmaceuticas y usos de los mismos | |
ECSP045229A (es) | Piridinonas sustituidas como moduladores de la p38 map quinasa | |
UY30498A1 (es) | Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones | |
AR069165A1 (es) | Derivados de 4-bencilamino-1-carboxacilpiperidina como inhibidores de cetp utiles para el tratamiento de hiperlipidemia | |
AR076460A1 (es) | Antagonistas del receptor cxcr3 | |
AR054783A1 (es) | Derivados de pirrolo-quinolinas moduladores selectivos de receptores de androgeno | |
AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
AR049346A1 (es) | 3-amino-1-arilpropil-indoles como inhibidores de reabsorcion de monoaminas | |
AR059428A1 (es) | Pirazoles para el tratamiento de enfermedades mediadas por la modulacion de los receptores de histamina h3 y una composicion farmaceutica que los comprende. | |
AR076008A1 (es) | Derivados de hidroximetil-isoxazol moduladores de receptores gaba a, composiciones farmaceuticas que los contienen, metodo para prepararlos y uso de los mismos para el tratamiento del alzheimer y otros trastornos cognitivos. | |
UY30300A1 (es) | Compuestos triarílicos y sus derivados | |
AR082111A1 (es) | Furopiridinas o tienopiridinas condensadas, composiciones farmaceuticas que las contienen utiles para tratar trastornos psicoticos y del sistema nervioso central, y metodo de preparacion de las mismas | |
AR066103A1 (es) | Derivados de triazolopiridin - carboxamidas, su preparacion y su aplicacion en terapeutica | |
CO6260069A2 (es) | Tiazolopiridin-2-iloxi-fenil y tiazolopirazin-2-iloxi-fenil aminas como moduladores de la leucotrieno a4 hidrolasa | |
AR057525A1 (es) | Compuestos inhibidores selectivos de gsk3 y un proceso para su preparacion | |
ECSP088257A (es) | Derivados de amida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |